Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
stemcell
Press Release
Dec 7, 2020
Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19
Invitrx Therapeutics' continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company's collaboration with Baylx, Inc. (Baylx) to co-sponsor and spearhead the clinical trial of Baylx's FDA approved IND for COVID-19 indication using Human Umbilical Cord Tissue Mesenchymal Stem Cells (hUC-MSC) product, as featured by BioInformant on November 23, 2020. This publication can be seen in full at https://bioinformant.com/invitrx-baylx-covid-19.
Read More
Press Release
Jun 18, 2018
Royal Biologics Launches Maxx-Cell, the World's Most Advanced Bone Marrow Aspiration Device
Maxx-Cell has created a new gold standard in bone marrow aspiration therapy.
Read More
First
Prev
1
Next
Last
